News & Updates
Filter by Specialty:
Antipsychotic prescriptions for dementia soared during COVID-19 pandemic
The overall rate of antipsychotic drug prescriptions to patients with dementia increased markedly during the initial months of the COVID-19 pandemic, and did not return to prepandemic levels when the acute phase was over, a multinational network cohort study has shown.
Antipsychotic prescriptions for dementia soared during COVID-19 pandemic
02 Feb 2023
Physical activity helps prevent dementia, cognitive impairment in women
Walking daily and performing moderate-to-vigorous physical activity can help lower the risk of mild cognitive impairment (MCI) or dementia in ageing women, as shown in a study.
Physical activity helps prevent dementia, cognitive impairment in women
30 Jan 2023
Diabetes linked to elevated serum neurofilament light chain levels
A recent study has found an association between diabetes mellitus and higher serum neurofilament light chain (sNfL), biomarkers of neuroaxonal injury in multiple neurological diseases, in a US population.
Diabetes linked to elevated serum neurofilament light chain levels
28 Jan 2023
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.
Add-on cannabidiol induces sustained seizure reduction in treatment-resistant epilepsy
27 Jan 2023
Some antihypertensive medications may lower dementia risk
Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), angiotensin receptor blockers (ARBs), and dihydropyridine calcium channel blockers (CCBs) helps reduce the risk of dementia over a decade, but this beneficial effect decreases over time, according to a study.